David L Rainwater1, Michael C Mahaney, John L VandeBerg, Xing Li Wang. 1. Department of Genetics and the Southwest National Primate Research Center, Southwest Foundation for Biomedical Research, San Antonio, TX 78245-0549, USA. david@sfbrgenetics.org
Abstract
BACKGROUND: Oxidative stress is a widely accepted risk factor for cardiovascular disease (CVD), but the CVD benefit of dietary antioxidants, such as vitamin E, is controversial. OBJECTIVE: Therefore, we have investigated, in the baboon model, the effects of dietary vitamin E supplementation on risk factors for CVD. DESIGN: Pedigreed baboons (n = 251) were fed 2 atherogenic diets, high in fat and cholesterol, that differed in vitamin E concentrations. After 7 wk on each diet, blood samples were taken, and a panel of CVD risk factor traits (ie, indicators of lipoprotein metabolism and oxidative stress) were measured. RESULTS: Vitamin E supplementation caused significantly higher total antioxidant status (TAS) and lower oxidized LDL as expected. In addition, vitamin E caused 2 paradoxical effects on HDL metabolism: higher apolipoprotein A-I (apo A-I) concentrations and lower HDL sizes. We calculated a difference (Delta) variable for each trait as the value on the high-vitamin E diet minus that on the low-vitamin E diet and determined that several HDL concentration Delta variables were significantly correlated with Delta TAS, but only one, Delta apo A-I, was independently correlated. Genetic analyses showed that 2 Delta variables, Delta paraoxonase and Delta HDL(2), were significantly heritable, but that neither Delta TAS nor Delta apo A-I were heritable. CONCLUSIONS: Thus, our data show that dietary vitamin E improves TAS and LDL quality. They also show 2 apparently paradoxical effects on HDL metabolism: lower HDL(2), which is mediated by genes, and higher apo A-I, which is not. These effects have contrasting associations with CVD risk and may help account for the mixed results from clinical trials of dietary vitamin E.
BACKGROUND: Oxidative stress is a widely accepted risk factor for cardiovascular disease (CVD), but the CVD benefit of dietary antioxidants, such as vitamin E, is controversial. OBJECTIVE: Therefore, we have investigated, in the baboon model, the effects of dietary vitamin E supplementation on risk factors for CVD. DESIGN: Pedigreed baboons (n = 251) were fed 2 atherogenic diets, high in fat and cholesterol, that differed in vitamin E concentrations. After 7 wk on each diet, blood samples were taken, and a panel of CVD risk factor traits (ie, indicators of lipoprotein metabolism and oxidative stress) were measured. RESULTS: Vitamin E supplementation caused significantly higher total antioxidant status (TAS) and lower oxidized LDL as expected. In addition, vitamin E caused 2 paradoxical effects on HDL metabolism: higher apolipoprotein A-I (apo A-I) concentrations and lower HDL sizes. We calculated a difference (Delta) variable for each trait as the value on the high-vitamin E diet minus that on the low-vitamin E diet and determined that several HDL concentration Delta variables were significantly correlated with Delta TAS, but only one, Delta apo A-I, was independently correlated. Genetic analyses showed that 2 Delta variables, Delta paraoxonase and Delta HDL(2), were significantly heritable, but that neither Delta TAS nor Delta apo A-I were heritable. CONCLUSIONS: Thus, our data show that dietary vitamin E improves TAS and LDL quality. They also show 2 apparently paradoxical effects on HDL metabolism: lower HDL(2), which is mediated by genes, and higher apo A-I, which is not. These effects have contrasting associations with CVD risk and may help account for the mixed results from clinical trials of dietary vitamin E.
Authors: Dan Farbstein; Shany Blum; Mordechai Pollak; Roy Asaf; Hilla Lee Viener; Orit Lache; Rabea Asleh; Rachel Miller-Lotan; Ido Barkay; Michael Star; Avery Schwartz; Shiri Kalet-Littman; David Ozeri; Jacob Vaya; Hagai Tavori; Moshe Vardi; Arie Laor; Stephen E Bucher; Yefim Anbinder; Doron Moskovich; Nur Abbas; Netta Perry; Yishai Levy; Andrew P Levy Journal: Atherosclerosis Date: 2011-06-13 Impact factor: 5.162
Authors: Hilla-Lee Veiner; Rostic Gorbatov; Moshe Vardi; Gheorghe Doros; Rachel Miller-Lotan; Yaniv Zohar; Edmond Sabo; Rabea Asleh; Nina S Levy; Levi J Goldfarb; Thomas A Berk; Tali Haas; Hadar Shalom; Edith Suss-Toby; Adi Kam; Marielle Kaplan; Ronit Tamir; Anna Ziskind; Andrew P Levy Journal: Atherosclerosis Date: 2015-01-14 Impact factor: 5.162
Authors: Peter W Nathanielsz; Jian Yan; Ralph Green; Mark Nijland; Joshua W Miller; Guoyao Wu; Thomas J McDonald; Marie A Caudill Journal: Physiol Rep Date: 2015-11